Conmed Overview
- Year Founded
-
1970

- Status
-
Public
- Employees
-
3,900

- Stock Symbol
-
CNMD

- Investments
-
15
- Share Price
-
$52.19
- (As of Friday Closing)
Conmed General Information
Description
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The Company's products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Geographically operates in USA, Europe, Middle East & Africa, Asia Pacific and North America. Majority is revenue is from USA.
Contact Information
Website
www.conmed.comCorporate Office
- 11311 Concept Boulevard
- Largo, FL 33773
- United States
Corporate Office
- 11311 Concept Boulevard
- Largo, FL 33773
- United States
Conmed Timeline
Conmed Stock Performance
As of 20-Jun-2025, Conmed’s stock price is $52.19. Its current market cap is $1.61B with 30.9M shares.
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$52.19 | $52.08 | $46.00 - $78.19 | $1.61B | 30.9M | 453K | $3.84 |
Conmed Financials Summary
As of 31-Mar-2025, Conmed has a trailing 12-month revenue of $1.32B.
In Thousands, USD |
TTM 31-Mar-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
---|---|---|---|---|
EV | 2,747,907 | 3,016,514 | 4,349,962 | 3,705,282 |
Revenue | 1,315,998 | 1,307,015 | 1,244,744 | 1,045,472 |
EBITDA | 253,343 | 272,183 | 192,477 | 27,562 |
Net Income | 118,751 | 132,423 | 64,459 | (80,582) |
Total Assets | 2,297,683 | 2,306,247 | 2,300,021 | 2,297,592 |
Total Debt | 892,157 | 905,781 | 973,848 | 1,054,822 |
Conmed Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Conmed Comparisons
Industry
Financing
Details
Conmed Competitors (3)
One of Conmed’s 3 competitors is Teleflex, a Corporation company based in Wayne, PA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Teleflex | Corporation | Wayne, PA | ||||
Stryker | Formerly VC-backed | Portage, MI | ||||
Depuy Mitek | Corporation | Raynham, MA |
Conmed Patents
Conmed Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-4565301-A1 | Multimodal surgical gas delivery system having continous pressure monitoring | Pending | 05-Aug-2022 | ||
EP-4558201-A1 | System and method for controlling insufflation gas concentration using an optical oxygen sensor | Pending | 21-Jul-2022 | ||
EP-4493243-A1 | Surgical gas delivery system for gas sealed insufflation and recirculation with pneumatically powered blocking valves | Pending | 14-Mar-2022 | ||
US-20250152906-A1 | Surgical gas delivery system for gas sealed insufflation and recirculation with pneumatically powered blocking valves | Pending | 14-Mar-2022 | ||
CA-3231377-A1 | Access ports for use with surgical robots | Pending | 15-Nov-2021 | A61B17/3423 |
Conmed Signals
Conmed Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Conmed Investments & Acquisitions (15)
Conmed’s most recent deal was a Merger/Acquisition with BioRez for . The deal was made on 09-Aug-2022.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
BioRez | 09-Aug-2022 | Merger/Acquisition | Therapeutic Devices | ||
In2Bones | 13-Jun-2022 | Merger/Acquisition | Therapeutic Devices | ||
Buffalo Filter | 11-Feb-2019 | Merger/Acquisition | Surgical Devices | ||
MedShape (ACL Product Line) | 03-Jul-2017 | Corporate Asset Purchase | Buildings and Property | ||
SurgiQuest | 04-Jan-2016 | Merger/Acquisition | Surgical Devices |
Conmed ESG
Risk Overview
Risk Rating
Updated October, 15, 2024
27.57 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,673
Rank
Percentile

Healthcare
Industry
of 564
Rank
Percentile

Medical Devices
Subindustry
of 196
Rank
Percentile

Conmed Exits (1)
Conmed’s most recent exit was on 08-Jan-2003 from Core Dynamics. The exit was categorized as .
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
Core Dynamics | 08-Jan-2003 | Completed |
|
Conmed FAQs
-
When was Conmed founded?
Conmed was founded in 1970.
-
Where is Conmed headquartered?
Conmed is headquartered in Largo, FL.
-
What is the size of Conmed?
Conmed has 3,900 total employees.
-
What industry is Conmed in?
Conmed’s primary industry is Surgical Devices.
-
Is Conmed a private or public company?
Conmed is a Public company.
-
What is Conmed’s stock symbol?
The ticker symbol for Conmed is CNMD.
-
What is the current stock price of Conmed?
As of 20-Jun-2025 the stock price of Conmed is $52.19.
-
What is the current market cap of Conmed?
The current market capitalization of Conmed is $1.61B.
-
What is Conmed’s current revenue?
The trailing twelve month revenue for Conmed is $1.32B.
-
Who are Conmed’s competitors?
Teleflex, Stryker, and Depuy Mitek are competitors of Conmed.
-
What is Conmed’s annual earnings per share (EPS)?
Conmed’s EPS for 12 months was $3.84.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »